ELAN PHARMACEUTICAL INVESTMENTS LTD 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jun 17, 2004
Insider Transaction Report
Form 4
ELAN CORP PLC
10% Owner
Transactions
- Sale
Common Stock
2004-06-15$1.96/sh−2,036,148$3,990,850→ 347,788 total(indirect: I)
Footnotes (1)
- [F1]The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd.